ATE231507T1 - Synthese von azyklischen nukleosiden - Google Patents

Synthese von azyklischen nukleosiden

Info

Publication number
ATE231507T1
ATE231507T1 AT97903709T AT97903709T ATE231507T1 AT E231507 T1 ATE231507 T1 AT E231507T1 AT 97903709 T AT97903709 T AT 97903709T AT 97903709 T AT97903709 T AT 97903709T AT E231507 T1 ATE231507 T1 AT E231507T1
Authority
AT
Austria
Prior art keywords
azyclic
nucleosides
synthesis
azyclic nucleosides
Prior art date
Application number
AT97903709T
Other languages
English (en)
Inventor
Per Engelhardt
Marita Hoegberg
Xiao-Xiong Zhou
Bjoern Lindborg
Nils Gunnar Johansson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600613A external-priority patent/SE9600613D0/xx
Priority claimed from SE9600614A external-priority patent/SE9600614D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of ATE231507T1 publication Critical patent/ATE231507T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97903709T 1996-02-16 1997-02-14 Synthese von azyklischen nukleosiden ATE231507T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600613A SE9600613D0 (sv) 1996-02-16 1996-02-16 Acyclic nucleoside derivatives
SE9600614A SE9600614D0 (sv) 1996-02-16 1996-02-16 Antiviral compounds
PCT/SE1997/000242 WO1997030052A1 (en) 1996-02-16 1997-02-14 Synthesis of acyclic nucleosides

Publications (1)

Publication Number Publication Date
ATE231507T1 true ATE231507T1 (de) 2003-02-15

Family

ID=26662518

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97903708T ATE231508T1 (de) 1996-02-16 1997-02-14 Azyklische nukleosidderivate
AT97903709T ATE231507T1 (de) 1996-02-16 1997-02-14 Synthese von azyklischen nukleosiden

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97903708T ATE231508T1 (de) 1996-02-16 1997-02-14 Azyklische nukleosidderivate

Country Status (25)

Country Link
US (5) US5869493A (de)
EP (2) EP0880521B1 (de)
JP (2) JP4171069B2 (de)
KR (1) KR100464692B1 (de)
CN (1) CN1067073C (de)
AR (1) AR005827A1 (de)
AT (2) ATE231508T1 (de)
AU (1) AU715062B2 (de)
BG (1) BG64179B1 (de)
CA (1) CA2243826C (de)
CZ (1) CZ292169B6 (de)
DE (2) DE69718626T2 (de)
DK (1) DK0888348T3 (de)
EA (2) EA002809B1 (de)
ES (2) ES2189942T3 (de)
HU (1) HU229865B1 (de)
IL (1) IL124760A (de)
MY (1) MY123083A (de)
NO (1) NO322930B1 (de)
NZ (1) NZ330472A (de)
PL (1) PL184892B1 (de)
SK (1) SK284613B6 (de)
TR (1) TR199801318T2 (de)
TW (1) TW533213B (de)
WO (2) WO1997030051A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
WO1998021223A1 (en) * 1996-11-12 1998-05-22 Medivir Ab Nucleosides
US6184376B1 (en) * 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
ATE227289T1 (de) * 1997-02-10 2002-11-15 Medivir Ab Verfahren zur herstellung von azyklischen nukleosiden
SI0988304T1 (en) * 1997-08-15 2001-08-31 Medivir Ab Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
WO1999032490A1 (en) * 1997-12-19 1999-07-01 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
TW200510415A (en) * 2003-04-30 2005-03-16 Teva Pharma Process for the preparation of famciclovir
EA011039B1 (ru) 2004-12-30 2008-12-30 Медивир Аб Приемлемые для лечения вич соединения
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
CN101033238B (zh) * 2006-03-06 2011-02-16 中国科学院上海药物研究所 嘌呤类化合物双氨基酸酯的制备方法和用途
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
US9296776B2 (en) 2007-07-09 2016-03-29 Eastern Virginia Medical School Substituted nucleoside derivatives with antiviral and antimicrobial properties
MX2010003056A (es) * 2007-09-21 2010-04-07 Epiphany Biosciences Inc Polimorfos de valomaciclovir.
WO2011022712A1 (en) * 2009-08-21 2011-02-24 Epiphany Biosciences, Inc. Method of treating infectious mononucleosis with acylic nucleoside derivatives
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
KR101763127B1 (ko) 2015-06-23 2017-08-01 (주)농협아그로 끈끈이 엠보싱 트랩 테이프
WO2024118480A1 (en) * 2022-11-28 2024-06-06 Epiphany Biosciences Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116282A (en) 1960-04-27 1963-12-31 Upjohn Co Pyrimidine nucleosides and process
FR2040177A1 (en) 1969-01-31 1971-01-22 Robugen Gmbh 2-deoxyribosyl-uracil derivs
US3817982A (en) 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4267171A (en) 1979-07-02 1981-05-12 The Regents Of The University Of California C-5 Substituted cytosine nucleosides
US4247544A (en) 1979-07-02 1981-01-27 The Regents Of The University Of California C-5 Substituted uracil nucleosides
JPS57146798A (en) 1981-03-06 1982-09-10 Yamasa Shoyu Co Ltd Hexosyl nucleoside derivative
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
EP0286825A3 (de) 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von 3'-fluro-3'-deoxythymidine zur Herstellung von medicamenten zur Behandlung von Viruskrankheiten
SE8701605D0 (sv) 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
EP0339075B1 (de) * 1987-10-28 1993-08-18 Pro-Neuron, Inc. Acylatiertes uridin und cytidin und deren verwendungen
SE8704298D0 (sv) 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
US5284837A (en) 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
SE8802173D0 (sv) 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
AU618436B2 (en) * 1988-12-19 1991-12-19 Wellcome Foundation Limited, The Antiviral cytosine and guanine derivatives
FI95384C (fi) 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5874578A (en) 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
DE4311801A1 (de) * 1993-04-09 1994-10-13 Hoechst Ag Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (de) * 1993-11-18 1996-08-01 Ajinomoto Kk
US5521161A (en) 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
JP3906488B2 (ja) 1995-02-21 2007-04-18 味の素株式会社 プリン誘導体の製造方法
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
WO1997027198A1 (en) * 1996-01-26 1997-07-31 F.Hoffmann-La Roche Ag Process for preparing purine derivatives
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
AU1592897A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) * 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
EP0827960A1 (de) 1996-09-10 1998-03-11 Ajinomoto Co., Inc. Verfahren zur Herstellung von Purinderivaten

Also Published As

Publication number Publication date
IL124760A0 (en) 1999-01-26
EA199800729A1 (ru) 1999-02-25
ES2189941T3 (es) 2003-07-16
ATE231508T1 (de) 2003-02-15
ES2189942T3 (es) 2003-07-16
JP2000504721A (ja) 2000-04-18
NZ330472A (en) 2000-02-28
WO1997030052A1 (en) 1997-08-21
KR19990082571A (ko) 1999-11-25
AR005827A1 (es) 1999-07-14
EA002809B1 (ru) 2002-10-31
BG102647A (en) 1999-04-30
EA200000787A1 (ru) 2001-04-23
JP4171069B2 (ja) 2008-10-22
PL328335A1 (en) 1999-01-18
US6576763B1 (en) 2003-06-10
DE69718619D1 (de) 2003-02-27
TW533213B (en) 2003-05-21
EP0880521B1 (de) 2003-01-22
SK98598A3 (en) 1998-12-02
KR100464692B1 (ko) 2005-06-21
HK1015773A1 (en) 1999-10-22
CA2243826C (en) 2005-12-27
EP0888348B1 (de) 2003-01-22
EP0880521A1 (de) 1998-12-02
TR199801318T2 (xx) 1998-10-21
US5869493A (en) 1999-02-09
AU1818297A (en) 1997-09-02
AU1818397A (en) 1997-09-02
WO1997030051A1 (en) 1997-08-21
IL124760A (en) 2003-09-17
NO322930B1 (no) 2006-12-18
CN1210537A (zh) 1999-03-10
PL184892B1 (pl) 2003-01-31
CZ292169B6 (cs) 2003-08-13
EA001404B1 (ru) 2001-02-26
HUP9900680A3 (en) 2001-02-28
DE69718619T2 (de) 2003-08-21
DK0888348T3 (da) 2003-04-14
US20120123119A1 (en) 2012-05-17
CA2243826A1 (en) 1997-08-21
BG64179B1 (bg) 2004-03-31
DE69718626D1 (de) 2003-02-27
MY123083A (en) 2006-05-31
CN1067073C (zh) 2001-06-13
US20090076041A1 (en) 2009-03-19
US8124609B2 (en) 2012-02-28
AU713916B2 (en) 1999-12-16
DE69718626T2 (de) 2003-09-11
EP0888348A1 (de) 1999-01-07
AU715062B2 (en) 2000-01-13
CZ232298A3 (cs) 1998-10-14
HU229865B1 (en) 2014-10-28
HUP9900680A2 (hu) 1999-06-28
SK284613B6 (sk) 2005-07-01
NO983216D0 (no) 1998-07-13
US6255312B1 (en) 2001-07-03
NO983216L (no) 1998-10-13
JP2000504720A (ja) 2000-04-18

Similar Documents

Publication Publication Date Title
DE69924930D1 (de) Synthese von Oligonukleotiden
ATE231507T1 (de) Synthese von azyklischen nukleosiden
NO20001950D0 (no) Syntese av SAPO-44
ATE196463T1 (de) Assymetrische synthese von (-) 6-chloro-4-
DE69916582D1 (de) Synthese von zsm-48
DE69711667D1 (de) Gensyntheseverfahren
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
DE69620399D1 (de) Sprachsynthese
FI944568L (fi) Oligonukleotidien synteesi
ATE186903T1 (de) Synthese von cyclopropylacetylen
NO982850D0 (no) Ny syntese
DE69501534D1 (de) Synthese von 1,1,1,3,3-Pentafluorpropan
DE59902179D1 (de) Elektrochemische synthese von perfluoralkylfluorophosphoranen
BR9509436A (pt) Inibidores de síntese de apoliproteina-B
DE69912206D1 (de) Verbesserte Synthese von Haloformiminverbindungen
DE69310372D1 (de) Synthesereaktionssäule
DE69801344D1 (de) Synthese von Bis(Phthalocyanylalumino)tetraphenyldisiloxanen
FI973591A0 (fi) Nya syntetiserade kryptofysiner
DE69823824D1 (de) Melamin-synthese-anlage und melamin synthese
ATE259827T1 (de) Parenterale zubereitung des alatrofloxacins
FI945705A7 (fi) Bisindolyylimaleimidien parannettu synteesi
DE69722585D1 (de) Synthese von wellenformen
DE69602937D1 (de) Verbesserte synthese von racemischen metallocenen
DE69226706D1 (de) Synthese von smektit-tonmineralen
BR9711363A (pt) Sintese de bis-indolilmaleimidas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties